Related Experiment Video

Updated: Aug 19, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Nosocomial viral pneumonia in the intensive care unit

R C Holladay1, G D Campbell

  • 1Louisiana State University Medical Center, Shreveport, USA.

Clinics in Chest Medicine
|March 1, 1995
PubMed

Insights

Viral pneumonias in intensive care units (ICUs) are underdiagnosed because they mimic bacterial infections. New diagnostics and antivirals now enable faster detection and treatment of these critical respiratory illnesses.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Virology

Background:

  • The role of viruses in hospital-acquired pneumonia (HAP), particularly in intensive care units (ICUs), is often underestimated.
  • Viral pneumonias present clinical challenges, often being indistinguishable from bacterial pneumonias through standard diagnostic methods.
  • Factors increasing suspicion for viral pneumonia include lack of response to antibiotics, seasonal occurrence (winter), and concurrent hospital or community viral outbreaks.

Purpose of the Study:

  • To highlight the underrecognized incidence and diagnostic challenges of viral pneumonias in the ICU setting.
  • To emphasize the importance of considering viral etiologies in ICU pneumonia cases, especially when bacterial causes are not evident or responsive to treatment.
  • To discuss the impact of recent advancements in diagnostics and antiviral therapies on managing viral pneumonia.

Main Methods:

  • Review of existing literature on viral ICU pneumonias.
  • Analysis of clinical presentation and diagnostic limitations for viral versus bacterial pneumonia.
  • Discussion of emerging diagnostic technologies and antiviral treatments.

Main Results:

  • Viral ICU pneumonias are likely significantly underdiagnosed due to diagnostic limitations.
  • Clinical indicators such as non-response to antimicrobials and seasonality can suggest viral causes.
  • Recent advances in diagnostics and therapeutics offer improved potential for timely identification and management.

Conclusions:

  • Accurate diagnosis and treatment of viral ICU pneumonia are crucial for improving patient outcomes.
  • Increased awareness and utilization of advanced diagnostic tools are needed to combat underestimation of viral pathogens.
  • The advent of effective antiviral agents necessitates prompt diagnosis to initiate appropriate therapy.

More Related Videos

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...